AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of CLP 312.90 trillion. The enterprise value is 369.53 trillion.

Market Cap	312.90T
Enterprise Value	369.53T

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Apr 15, 2026

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	75.33%
Float	1.77B

Valuation Ratios

The trailing PE ratio is 82.98 and the forward PE ratio is 13.89.

PE Ratio	82.98
Forward PE	13.89
PS Ratio	5.68
PB Ratio	-107.61
P/TBV Ratio	n/a
P/FCF Ratio	19.50
P/OCF Ratio	18.25
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.91, with an EV/FCF ratio of 23.03.

EV / Earnings	98.00
EV / Sales	6.74
EV / EBITDA	13.91
EV / EBIT	19.53
EV / FCF	23.03

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.41
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.84
Interest Coverage	7.30

Financial Efficiency

Return on equity (ROE) is 6,225.00% and return on invested capital (ROIC) is 22.49%.

Return on Equity (ROE)	6,225.00%
Return on Assets (ROA)	9.81%
Return on Invested Capital (ROIC)	22.49%
Return on Capital Employed (ROCE)	23.29%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	966.51M
Profits Per Employee	66.15M
Employee Count	57,000
Asset Turnover	0.45
Inventory Turnover	3.80

Taxes

In the past 12 months, AbbVie has paid 2.13 trillion in taxes.

Income Tax	2.13T
Effective Tax Rate	35.83%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	171,590.00
200-Day Moving Average	171,590.00
Relative Strength Index (RSI)	29.67
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.07

Income Statement

In the last 12 months, AbbVie had revenue of CLP 55.09 trillion and earned 3.77 trillion in profits. Earnings per share was 2,125.82.

Revenue	55.09T
Gross Profit	39.46T
Operating Income	19.02T
Pretax Income	5.94T
Net Income	3.77T
EBITDA	26.35T
EBIT	19.02T
Earnings Per Share (EPS)	2,125.82

Balance Sheet

The company has 4.74 trillion in cash and 61.61 trillion in debt, giving a net cash position of -56,877.32 billion.

Cash & Cash Equivalents	4.74T
Total Debt	61.61T
Net Cash	-56,877.32B
Net Cash Per Share	n/a
Equity (Book Value)	-2,907.69B
Book Value Per Share	-1,666.13
Working Capital	-12,815.25B

Cash Flow

In the last 12 months, operating cash flow was 17.14 trillion and capital expenditures -1,093.53 billion, giving a free cash flow of 16.05 trillion.

Operating Cash Flow	17.14T
Capital Expenditures	-1,093.53B
Depreciation & Amortization	7.26T
Net Borrowing	-271.01B
Free Cash Flow	16.05T
FCF Per Share	n/a

Margins

Gross margin is 71.62%, with operating and profit margins of 34.52% and 6.91%.

Gross Margin	71.62%
Operating Margin	34.52%
Pretax Margin	10.79%
Profit Margin	6.91%
EBITDA Margin	47.83%
EBIT Margin	34.52%
FCF Margin	29.13%

Dividends & Yields

This stock pays an annual dividend of 6,234.60, which amounts to a dividend yield of 3.63%.

Dividend Per Share	6,234.60
Dividend Yield	3.63%
Dividend Growth (YoY)	33.58%
Years of Dividend Growth	3
Payout Ratio	275.84%
Buyback Yield	n/a
Shareholder Yield	3.63%
Earnings Yield	1.21%
FCF Yield	5.13%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.26 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	8